This site is intended only for healthcare professionals resident in the Republic of Ireland




Sign in or registerLog out Our medicinesTherapy areasExplore contentExplore contentMaterialsVideosPodcastsLet’s connectLet's connectContact usSign up
PortfolioSupport & ResourcesPatient support 



Pfizer Endocrine Care

Pfizer has an excellent heritage in endocrinology and remains highly committed to its endocrine product portfolio. Our portfolio includes treatments for Acromegaly and daily and weekly treatments for Growth Hormone Deficiency as part of our focus on rare disease.1,2,3


View our portfolio of treatments for Acromegaly and Growth Hormone Deficiency.1,2,3

Portfolio Information Loading
Support & Resources

Learn more about patient resources available to support your patients.

Patient support resources Loading
References:Somavert Summary of Product CharacteristicsGenotropin Summary of Product CharacteristicsNGENLA® Summary of Product CharacteristicsPrescribing InformationSomavert Prescribing Information

Genotropin Prescribing Information

Ngenla Prescribing Information

Legal Category: S1A
Further information is available upon request

PP-UNP-IRL-0363 December 2022

Adverse events should be reported. Report an adverse event to your national reporting system (HPRA Pharmacovigilance)

Adverse events should also be reported to Pfizer Medical Information on 1800 633 363

PfizerPro AccountPfizerPro Account

Please sign in or register to gain access to information relating to Pfizer medicines and vaccines, medical conditions, patient materials and services.

Sign in or RegisterRegisterAccountLog out

This site is intended only for healthcare professionals resident in the Republic of Ireland. If you are a member of the public wishing to access information on a specific medicine, please visit


This website is brought to you by Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland. Registered in the Republic of Ireland No. 127002.


Copyright © 2023 Pfizer Limited. All rights reserved.

PP-UNP-IRL-0176. January 2023
For Healthcare Professionals in the Republic of Ireland *

The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.

I confirm that I am a healthcare professional resident in the Republic of Ireland.*

I accept and agree to the terms of use.*

If you select 'No', you will be redirected to, where you will be able to access information on Pfizer Healthcare Ireland.

PP-UNP-IRL-0176. January 2023

Yes No
You are now leaving PfizerPro
You are now leaving PfizerPro Ireland. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer. Pfizer accepts no responsibility for the content or services of the linked site.